Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer’s Disease using Cerebrospinal Fluid Biomarkers in the AIBL Study

被引：0
作者：
Samantha C. Burnham
P. M. Coloma
Q.-X. Li
S. Collins
G. Savage
S. Laws
J. Doecke
P. Maruff
R. N. Martins
D. Ames
C. C. Rowe
C. L. Masters
V. L. Villemagne
机构：
[1] CSIRO Health & Biosecurity,Personalised Health Care
[2] F. Hoffmann-La Roche Ltd, Data Science
[3] The University of Melbourne,Florey Institute of Neuroscience and Mental Health
[4] The University of Melbourne,Department of Pathology
[5] Macquarie University,ARC Centre of Excellence in Cognition and its Disorders (CCD) and Department of Psychology
[6] Edith Cowan University,School of Medical and Health Sciences
[7] Curtin University,School of Pharmacy and Biomedical Sciences
[8] CSIRO Health & Biosecurity,Department of Biomedical Sciences
[9] Cogstate Ltd,The University of Melbourne
[10] Macquarie University,Department of Molecular Imaging and Therapy
[11] National Ageing Research Institute (NARI),Department of Medicine
[12] Austin Health,undefined
[13] Austin Health,undefined
来源：
The Journal of Prevention of Alzheimer's Disease | 2019年 / 6卷
关键词：
Alzheimer’s disease; biomarkers; progression; longitudinal;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：248 / 255
页数：7
相关论文
共 71 条
[1]  
Blennow K(2006)Alzheimer’s disease Lancet 368 387-403
[2]  
de Leon MJ(2011)Neuropathological alterations in Alzheimer disease Cold Spring Harb Perspect Med 1 a006189-547
[3]  
Zetterberg H(2016)A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers Neurology 87 539-562
[4]  
Serrano-Pozo A(2018)NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease Alzheimers Dement 14 535-356
[5]  
Frosch MP(2002)The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics Science 297 353-608
[6]  
Masliah E(2016)The amyloid hypothesis of Alzheimer’s disease at 25 years EMBO Mol Med 8 595-367
[7]  
Hyman BT(2013)Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study Lancet Neurol 12 357-1303
[8]  
Jack CR(2010)3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects Neurobiol Aging 31 1284-S
[9]  
Bennett DA(2012)Brain imaging in Alzheimer disease Cold Spring Harb Perspect Med 2 a006213-102
[10]  
Blennow K(2010)CSF biomarkers in Alzheimer’s disease — use in clinical diagnosis and to monitor treatment effects Eur Neuropsychopharmacol 20 S159-464
12345678